Trials / Completed
CompletedNCT01699542
WallFlex Esophageal Fully Covered (FC) Benign Anastomotic Stricture
A Multi-Center, Prospective, Randomized (RCT) Study Comparing WallFlex® Esophageal Fully Covered (FC) Metal Stent to Bougie Dilation for the Treatment of Refractory Anastomotic Esophageal Strictures
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this of this study is to compare the safety and effectiveness of temporary indwell of the WallFlex Esophageal FC Metal Stent to Bougie Dilation for the treatment of refractory anastomotic esophageal strictures
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | WallFlex Esophageal RX Fully Covered Stent | Temporary placement of the WallFlex Esophageal RX Fully Covered Stent for treatment of refractory anastomotic esophageal strictures. The stent will be removed after 8 weeks (plus or minus 7 days) indwell |
| DEVICE | Esophageal Bougie Dilator Per Investigator preference | Commercially available Esophageal Bougie Dilator Per Investigator preference |
Timeline
- Start date
- 2013-12-23
- Primary completion
- 2016-09-25
- Completion
- 2016-09-25
- First posted
- 2012-10-03
- Last updated
- 2021-06-28
- Results posted
- 2021-06-28
Locations
4 sites across 3 countries: Brazil, Netherlands, Sweden
Source: ClinicalTrials.gov record NCT01699542. Inclusion in this directory is not an endorsement.